186 related articles for article (PubMed ID: 32470159)
1. Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy.
Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Spolverato G; Maithel SK; Pawlik TM
J Surg Oncol; 2020 Sep; 122(3):442-449. PubMed ID: 32470159
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.
Dasari BVM; Al-Shakhshir S; Pawlik TM; Shah T; Marudanayagam R; Sutcliffe RP; Mirza DF; Muiesan P; Roberts KJ; Isaac J
J Gastrointest Surg; 2018 Sep; 22(9):1652-1658. PubMed ID: 29869091
[TBL] [Abstract][Full Text] [Related]
3. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
Sahara K; Tsilimigras DI; Mehta R; Moro A; Paredes AZ; Lopez-Aguiar AG; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho C; Beems M; Dillhoff M; Maithel SK; Endo I; Pawlik TM
Ann Surg Oncol; 2020 Apr; 27(4):1203-1212. PubMed ID: 31838609
[TBL] [Abstract][Full Text] [Related]
4. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined.
Zhang XF; Wu XN; Tsilimigras DI; Poultsides G; Rocha F; Abbott DE; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM;
J Surg Oncol; 2019 Dec; 120(8):1302-1310. PubMed ID: 31680243
[TBL] [Abstract][Full Text] [Related]
5. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.
Zhang XF; Xue F; Dong DH; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Lv Y; Maithel SK; Pawlik TM
Ann Surg; 2021 Jul; 274(1):e28-e35. PubMed ID: 31356277
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
7. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
[TBL] [Abstract][Full Text] [Related]
8. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
[TBL] [Abstract][Full Text] [Related]
9. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis.
Wu L; Sahara K; Tsilimigras DI; Maithel SK; Poultsides GA; Rocha FG; Weber SM; Fields RC; Idrees K; Cho CS; Shen F; Pawlik TM;
J Surg Oncol; 2019 Dec; 120(7):1080-1086. PubMed ID: 31468550
[TBL] [Abstract][Full Text] [Related]
11. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
[TBL] [Abstract][Full Text] [Related]
12. Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases.
Dong DH; Zhang XF; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM;
J Surg Oncol; 2019 Dec; 120(7):1071-1079. PubMed ID: 31571225
[TBL] [Abstract][Full Text] [Related]
13. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.
Margonis GA; Samaha M; Kim Y; Postlewait LM; Kunz P; Maithel S; Tran T; Berger N; Gamblin TC; Mullen MG; Bauer TW; Pawlik TM
J Gastrointest Surg; 2016 Jun; 20(6):1098-105. PubMed ID: 27008594
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes after Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors: Results from the US Neuroendocrine Study Group.
Sahara K; Tsilimigras DI; Moro A; Mehta R; Dillhoff M; Heidsma CM; Lopez-Aguiar AG; Maithel SK; Rocha FG; Kanji Z; Abbott DE; Fisher A; Fields RC; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho CS; Beems M; Endo I; Pawlik TM
Neuroendocrinology; 2021; 111(1-2):129-138. PubMed ID: 32040951
[TBL] [Abstract][Full Text] [Related]
17. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
Conrad C; Kutlu OC; Dasari A; Chan JA; Vauthey JN; Adams DB; Kim M; Fleming JB; Katz MH; Lee JE
J Gastrointest Surg; 2016 Dec; 20(12):1966-1974. PubMed ID: 27714644
[TBL] [Abstract][Full Text] [Related]
19. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
[TBL] [Abstract][Full Text] [Related]
20. Pancreaticoduodenectomy and metastasectomy for metastatic pancreatic neuroendocrine tumors.
Chawla A; Williams RT; Sich N; Clancy T; Wang J; Ashley S; Pezzi C; Swanson R
J Surg Oncol; 2018 Nov; 118(6):983-990. PubMed ID: 30212595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]